Howard Mark Katzenstein, MD

Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731; Journal of Pediatric Surgery; (2022).

Liver Tumors; Pediatric Oncology; (2022).

Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults; Journal of Hepatology; (2022).

Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee; Journal of Clinical Oncology; (2022).

Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study; Cancer; (2022).

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target; npj Precision Oncology; (2021).

Irradiating residual disease to 30 Gy with proton therapy in pediatric mediastinal Hodgkin lymphoma; International Journal of Particle Therapy; (2021).

Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults; bioRxiv; (2021).

A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma; Pediatric Blood & Cancer; (2021).

Neonatal Liver Tumors; Clinics in Perinatology; (2021).

Pediatric HCT in Florida (2014 -2016): A report from the FPBCC; Pediatric Transplantation; (2021).

Vaping the venom: Oral cavity cancer in a young adult with extensive electronic cigarette use; Pediatrics; (2021).

Successful use of transarterial radioembolization with yttrium-90 (TARE-Y90) in two children with hepatoblastoma; Pediatric Blood & Cancer; (2020).

A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors; Pediatric Blood and Cancer; (2020).

Concurrent Imatinib Dosing with High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients with Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia; Journal of Pediatric Hematology/Oncology; (2020).

Erratum: Chemotherapeutic approaches for newly diagnosed hepatoblastoma: Past, present, and future strategies (Journal of Clinical Oncology (2012) 59 (809-812) DOI: 10.1002/pbc.24219); Journal of Clinical Oncology; (2020).

Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee; Journal of Pediatric Surgery; (2020).

Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: A report from the children's Oncology group; Journal of Clinical Oncology; (2020).

Routine Surveillance Imaging Is Associated with Improved Postrelapse Survival in Patients with Ewing Sarcoma; Journal of Adolescent and Young Adult Oncology; (2020).

Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial; International Journal of Radiation Oncology Biology Physics; (2019).

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial; The Lancet Oncology; (2019).

Maintaining outstanding outcomes using response- And biology-based therapy for intermediate-risk neuroblastoma: A report from the children's oncology group study ANBL0531; Journal of Clinical Oncology; (2019).

Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma; Pediatric Blood & Cancer; (2019).

Priapism in a 13-year-old boy; Pediatrics in Review; (2018).

High-dose Chemotherapy is Efficacious and Well Tolerated in a Toddler with Aicardi Syndrome and Malignant Sacrococcygeal Teratoma; Journal of Pediatric Hematology/Oncology; (2018).

Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee; Cancer; (2017).

Prolonged isotretinoin in ultra high-risk neuroblastoma; Journal of Pediatric Hematology/Oncology; (2017).

Pulmonary relapse of osteosarcoma following presentation with a pneumomediastinum and localized disease at diagnosis; Journal of Pediatric Hematology/Oncology; (2017).

Correlation of Ezrin Expression Pattern and Clinical Outcomes in Ewing Sarcoma; Sarcoma; (2017).

Characterization of pulmonary metastases in children with hepatoblastoma treated on children's oncology group protocol AHEP0731 (The treatment of children with all stages of hepatoblastoma): A report from the children's oncology group; Journal of Clinical Oncology; (2017).

Respiratory difficulties in children with underlying asthma during immunotherapy for high-risk neuroblastoma; Journal of Pediatric Hematology/Oncology; (2017).

Heart transplantation for anthracycline cardiomyopathy: Pump up the volume; Pediatric Transplantation; (2017).

Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy; Cancer Chemotherapy and Pharmacology; (2016).

Cause and effect: the etiology of pediatric hepatocellular carcinoma and the role for liver transplantation; Pediatric Transplantation; (2016).

131I-Metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: A new approaches to neuroblastoma therapy (NANT) phase II study; Biology of Blood and Marrow Transplantation; (2015).

Outcomes after radiation therapy to metastatic sites in patients with stage 4 neuroblastoma; Journal of Pediatric Hematology/Oncology; (2015).

Towards an international pediatric liver tumor consensus classification: Proceedings of the Los Angeles COG liver tumors symposium; Modern Pathology; (2014).

Children's oncology Group's 2013 blueprint for research: Rare tumors; Pediatric Blood and Cancer; (2013).

A multicenter, first-in-pediatrics, phase 1, pharmacokinetic and pharmacodynamic study of ridaforolimus in patients with refractory solid tumors; Clinical Cancer Research; (2013).

Dose-intensive cisplatin for hepatoblastoma: Have you heard?; The Lancet Oncology; (2013).

Outcomes for patients with congenital hepatoblastoma; Pediatric Blood and Cancer; (2013).

Chemotherapeutic approaches for newly diagnosed hepatoblastoma: Past, present, and future strategies; Pediatric Blood and Cancer; (2012).

Colorectal adenocarcinoma: A pediatric case review with a focus on mismatch repair gene mutations and E-cadherin expression; Pediatric and Developmental Pathology; (2012).

Ewing Sarcoma with 7;22 translocation: Three new cases and clinicopathological characterization; Fetal and Pediatric Pathology; (2012).

Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas; Pediatric Blood and Cancer; (2012).

Successful treatment of an adolescent with locally advanced cervicovaginal clear cell adenocarcinoma using definitive chemotherapy and radiotherapy; Journal of Pediatric Hematology/Oncology; (2012).

Tandem stem cell rescue as consolidation therapy for high-risk neuroblastoma; Pediatric Blood and Cancer; (2012).

Treatment of hepatoblastoma: The North American cooperative group experience; Frontiers in Bioscience - Elite; (2012).

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study; Pediatric Blood and Cancer; (2011).

Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: A report from the Children's Oncology Group; Journal of Clinical Oncology; (2011).

Polycythemia in an infant secondary to granulocyte transfusions; Pediatric Blood and Cancer; (2011).

Primary congenital infantile fibrosarcoma of the heart: The first confirmed case; Annals of Thoracic Surgery; (2011).

The use of zoledronic acid in pediatric cancer patients; Pediatric Blood and Cancer; (2011).

Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: A review of eleven cases; Pediatric and Developmental Pathology; (2011).

Unusual presentation of congenital infantile fibrosarcoma in seven infants with molecular-genetic analysis; Fetal and Pediatric Pathology; (2011).

Unusual presentation of rosai-dorfman disease (RDD) in the bone in adolescents; Fetal and Pediatric Pathology; (2011).

Intracavitary cisplatin therapy for pediatric malignancies; Pediatric Blood and Cancer; (2010).

Irinotecan as maintenance therapy in high-risk hepatoblastoma; Pediatric Blood and Cancer; (2010).

NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary; Pediatric and Developmental Pathology; (2010).

Predictive power of pretreatment prognostic factors in children with hepatoblastoma: A report from the Children's Oncology Group; Pediatric Blood and Cancer; (2009).

Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: A study of the pediatric oncology experimental therapeutic investigators' consortium; Journal of Clinical Oncology; (2009).

Neuroblastoma; Current Problems in Cancer; (2009).

Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: The extracorporeal life support experience; Critical Care Medicine; (2009).

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: A report of the intergroup hepatoblastoma study p9645 as a part of the Children's Oncology Group; Cancer; (2009).

Anaplastic large cell neuroblastoma; Pediatric and Developmental Pathology; (2009).

Bronchioloalveolar carcinoma as a second malignancy in osteosarcoma survivors; Pediatric Blood and Cancer; (2009).

Excellent Local Control From Radiation Therapy for High-Risk Neuroblastoma; International Journal of Radiation Oncology Biology Physics; (2009).

Atypical hemolytic uremic syndrome responsive to steroids and intravenous immune globulin; Pediatric Blood and Cancer; (2009).

Redefining the role of doxorubicin for the treatment of children with hepatoblastoma; Journal of Clinical Oncology; (2008).

Intensity-Modulated Radiotherapy With Use of Cone-Down Boost for Pediatric Head-and-Neck Rhabdomyosarcoma; International Journal of Radiation Oncology Biology Physics; (2008).

Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma; Journal of Pediatric Surgery; (2007).

Predictive value of staging systems in hepatoblastoma [11]; Journal of Clinical Oncology; (2007).

Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17- demethoxygeldanamycinin pediatric patients with recurrent or refractory solid tumors: A pediatric oncology experimental therapeutics investigators consortium study; Clinical Cancer Research; (2007).

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma; Journal of Clinical Oncology; (2006).

Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects; Cancer Letters; (2005).

Gastrointestinal stromal tumors arising from the stomach: A report of three children; Journal of Pediatric Surgery; (2004).

Scintigraphic response by123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma; Journal of Clinical Oncology; (2004).

The role of angiogenesis in neuroblastoma: Clinical implications; American Journal of Cancer; (2003).

Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents; Journal of Pediatric Hematology/Oncology; (2003).

Pathologic quiz case: Ovarian mass in a 2-year-old girl presenting with pleural effusions.; Archives of pathology & laboratory medicine; (2003).

Metastatic malignant rhabdoid tumor of the liver treated with tandem high-dose therapy and autologous peripheral blood stem cell rescue [2]; Medical and Pediatric Oncology; (2003).

Increased microvascular density predicts relapse in Wilms' tumor; Journal of Pediatric Surgery; (2003).

Fibrolamellar hepatocellular carcinoma in children and adolescents; Cancer; (2003).

Advances in the diagnosis and treatment of neuroblastoma; Oncologist; (2003).

Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: Results of the Chicago Pilot II study; Journal of Clinical Oncology; (2002).

Hepatocellular carcinoma in children and adolescents: Results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study; Journal of Clinical Oncology; (2002).

Novel therapeutic approaches in the treatment of children with hepatoblastoma; Journal of Pediatric Hematology/Oncology; (2002).

Treatment of unresectable and metastatic hepatoblastoma: A Pediatric Oncology Group phase II study; Journal of Clinical Oncology; (2002).

Antiangiogenic therapy inhibits human neuroblastoma growth; Medical and Pediatric Oncology; (2001).

Treatment and outcome of 83 children with intraspinal neuroblastoma: The pediatric oncology group experience; Journal of Clinical Oncology; (2001).

Immunotherapeutic strategies in neuroblastoma: Antitumoral activity of deglycosylated Ricin a conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies; Medical and Pediatric Oncology; (2001).

MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN; Journal of Clinical Oncology; (2000).

Angiogenesis in neuroblastoma [2] (multiple letters); Journal of Clinical Oncology; (2000).

Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden; Clinical Cancer Research; (1999).

Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The pediatric oncology group experience - A pediatric oncology group study; Journal of Clinical Oncology; (1998).

Advances in the diagnosis and treatment of neuroblastoma; Current Opinion in Oncology; (1998).

Haploidentical related umbilical cord blood stem cell transplant in a child with acute non-lymphocytic leukemia; Bone Marrow Transplantation; (1997).

Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue; Bone Marrow Transplantation; (1997).